These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37614985)

  • 21. Trabectedin (ET-743) promotes differentiation in myxoid liposarcoma tumors.
    Forni C; Minuzzo M; Virdis E; Tamborini E; Simone M; Tavecchio M; Erba E; Grosso F; Gronchi A; Aman P; Casali P; D'Incalci M; Pilotti S; Mantovani R
    Mol Cancer Ther; 2009 Feb; 8(2):449-57. PubMed ID: 19190116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The myxoid liposarcoma specific TLS-CHOP fusion protein localizes to nuclear structures distinct from PML nuclear bodies.
    Thelin-Järnum S; Göransson M; Burguete AS; Olofsson A; Aman P
    Int J Cancer; 2002 Feb; 97(4):446-50. PubMed ID: 11802205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FUS/TLS-CHOP chimeric transcripts in liposarcoma tissues.
    Yang X; Nagasaki K; Egawa S; Maruyama K; Futami H; Tsukada T; Yokoyama R; Beppu Y; Fukuma H; Shimoda T
    Jpn J Clin Oncol; 1995 Dec; 25(6):234-9. PubMed ID: 8523819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SRC inhibition represents a potential therapeutic strategy in liposarcoma.
    Sievers E; Trautmann M; Kindler D; Huss S; Gruenewald I; Dirksen U; Renner M; Mechtersheimer G; Pedeutour F; Åman P; Nishio J; Schildhaus HU; Kirfel J; Schirmacher P; Wardelmann E; Buettner R; Hartmann W
    Int J Cancer; 2015 Dec; 137(11):2578-88. PubMed ID: 26084847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phosphatidylinositol-3-kinase (PI3K)/Akt Signaling is Functionally Essential in Myxoid Liposarcoma.
    Trautmann M; Cyra M; Isfort I; Jeiler B; Krüger A; Grünewald I; Steinestel K; Altvater B; Rossig C; Hafner S; Simmet T; Becker J; Åman P; Wardelmann E; Huss S; Hartmann W
    Mol Cancer Ther; 2019 Apr; 18(4):834-844. PubMed ID: 30787173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoclonality of multifocal myxoid liposarcoma: confirmation by analysis of TLS-CHOP or EWS-CHOP rearrangements.
    Antonescu CR; Elahi A; Healey JH; Brennan MF; Lui MY; Lewis J; Jhanwar SC; Woodruff JM; Ladanyi M
    Clin Cancer Res; 2000 Jul; 6(7):2788-93. PubMed ID: 10914725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sphingosine-1-phosphate and interleukin-1 independently regulate plasminogen activator inhibitor-1 and urokinase-type plasminogen activator receptor expression in glioblastoma cells: implications for invasiveness.
    Bryan L; Paugh BS; Kapitonov D; Wilczynska KM; Alvarez SM; Singh SK; Milstien S; Spiegel S; Kordula T
    Mol Cancer Res; 2008 Sep; 6(9):1469-77. PubMed ID: 18819934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genomic PCR detects tumor cells in peripheral blood from patients with myxoid liposarcoma.
    Panagopoulos I; Aman P; Mertens F; Mandahl N; Rydholm A; Bauer HF; Mitelman F
    Genes Chromosomes Cancer; 1996 Oct; 17(2):102-7. PubMed ID: 8913727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HSP90 inhibition blocks ERBB3 and RET phosphorylation in myxoid/round cell liposarcoma and causes massive cell death in vitro and in vivo.
    Safavi S; Järnum S; Vannas C; Udhane S; Jonasson E; Tomic TT; Grundevik P; Fagman H; Hansson M; Kalender Z; Jauhiainen A; Dolatabadi S; Stratford EW; Myklebost O; Eriksson M; Stenman G; Schneider-Stock R; Ståhlberg A; Åman P
    Oncotarget; 2016 Jan; 7(1):433-45. PubMed ID: 26595521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of genes differentially expressed in TLS-CHOP carrying myxoid liposarcomas.
    Thelin-Järnum S; Lassen C; Panagopoulos I; Mandahl N; Aman P
    Int J Cancer; 1999 Sep; 83(1):30-3. PubMed ID: 10449603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-6 and mevastatin regulate plasminogen activator inhibitor-1 through CCAAT/enhancer-binding protein-delta.
    Dong J; Fujii S; Li H; Nakabayashi H; Sakai M; Nishi S; Goto D; Furumoto T; Imagawa S; Zaman TA; Kitabatake A
    Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1078-84. PubMed ID: 15718495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fusion protein-driven IGF-IR/PI3K/AKT signals deregulate Hippo pathway promoting oncogenic cooperation of YAP1 and FUS-DDIT3 in myxoid liposarcoma.
    Berthold R; Isfort I; Erkut C; Heinst L; Grünewald I; Wardelmann E; Kindler T; Åman P; Grünewald TGP; Cidre-Aranaz F; Trautmann M; Fröhling S; Scholl C; Hartmann W
    Oncogenesis; 2022 Apr; 11(1):20. PubMed ID: 35459264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comprehensive review of the current evidence for trabectedin in advanced myxoid liposarcoma.
    Assi T; Kattan J; El Rassy E; Honore C; Dumont S; Mir O; Le Cesne A
    Cancer Treat Rev; 2019 Jan; 72():37-44. PubMed ID: 30468937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL-1 and IL-6 induce hepatocyte plasminogen activator inhibitor-1 expression through independent signaling pathways converging on C/EBPdelta.
    Dong J; Fujii S; Imagawa S; Matsumoto S; Matsushita M; Todo S; Tsutsui H; Sobel BE
    Am J Physiol Cell Physiol; 2007 Jan; 292(1):C209-15. PubMed ID: 16914534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of the novel monoclonal antibody against TLS/EWS-CHOP chimeric oncoproteins that is applicable to one of the most sensitive assays for myxoid and round cell liposarcomas.
    Oikawa K; Ishida T; Imamura T; Yoshida K; Takanashi M; Hattori H; Ishikawa A; Fujita K; Yamamoto K; Matsubayashi J; Kuroda M; Mukai K
    Am J Surg Pathol; 2006 Mar; 30(3):351-6. PubMed ID: 16538055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myxoid liposarcoma with EWS-CHOP type 1 fusion gene.
    Suzuki K; Matsui Y; Endo K; Kubo T; Hasegawa T; Kimura T; Ohtani O; Yasui N
    Anticancer Res; 2010 Nov; 30(11):4679-83. PubMed ID: 21115923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fusion of the EWS and CHOP genes in myxoid liposarcoma.
    Panagopoulos I; Höglund M; Mertens F; Mandahl N; Mitelman F; Aman P
    Oncogene; 1996 Feb; 12(3):489-94. PubMed ID: 8637704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasminogen activator inhibitor-1 is involved in interleukin-1β-induced matrix metalloproteinase expression in murine chondrocytes.
    Moritake A; Kawao N; Okada K; Ishida M; Tatsumi K; Matsuo O; Akagi M; Kaji H
    Mod Rheumatol; 2019 Nov; 29(6):959-963. PubMed ID: 30220231
    [No Abstract]   [Full Text] [Related]  

  • 39. High-Throughput Screening of Myxoid Liposarcoma Cell Lines: Survivin Is Essential for Tumor Growth.
    de Graaff MA; Malu S; Guardiola I; Kruisselbrink AB; de Jong Y; Corver WE; Gelderblom H; Hwu P; Nielsen TO; Lazar AJ; Somaiah N; Bovée JVMG
    Transl Oncol; 2017 Aug; 10(4):546-554. PubMed ID: 28654818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. On the role of c-Jun in the induction of PAI-1 gene expression by phorbol ester, serum, and IL-1alpha in HepG2 cells.
    Arts J; Grimbergen J; Toet K; Kooistra T
    Arterioscler Thromb Vasc Biol; 1999 Jan; 19(1):39-46. PubMed ID: 9888864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.